Antibiotics for community-acquired pneumonia in adult outpatients
There is insufficient evidence from randomised controlled trials (RCTs) on the efficacy of various antibiotic treatments in patients who are older than 12 years of age with a diagnosis of community acquired pneumonia (CAP).
CAP is associated with very high mortality and morbidity rates, particularly in the elderly population. Antibiotic treatment is one of the most common methods of treatment for CAP although it is often associated with increased antibacterial resistance and adverse effects. The aim of this review was to summarise all available evidence from RCTs on the efficacy of various antibacterial treatments for CAP in participants older than 12 years.
If you have found this summary helpful, please consider making a donation. If everyone who looked at our COVID-19 resources gave us just £2 per month, it would fund Evidence Aid’s life-saving work.